Gloria Melanie 4
4 · Immunovant, Inc. · Filed May 22, 2026
Research Summary
AI-generated summary of this filing
Immunovant (IMVT) COO Gloria Melanie Sells Shares
What Happened
Gloria Melanie, Chief Operating Officer of Immunovant, sold a total of 3,115 shares in open-market transactions on May 20, 2026, generating roughly $101,072 in proceeds. The sales break down as: 249 shares at a weighted average price of $30.41 ($7,572), 1,168 shares at $32.15 ($37,551), and 1,698 shares at $32.95 (~$55,949). These sales were reported as dispositions (transaction code S).
Key Details
- Transaction date: May 20, 2026; Form 4 filed May 22, 2026 (filed timely for a typical two-business-day reporting window).
- Total shares sold: 3,115; total proceeds: about $101,072.
- Price details / ranges (weighted averages and reported ranges):
- 249 shares at $30.41 (prices ranged $30.32–$31.00)
- 1,168 shares at $32.15 (prices ranged $31.55–$32.50)
- 1,698 shares at $32.95 (prices ranged $32.55–$33.49)
- Footnote: These sales were "sell-to-cover" transactions to satisfy tax withholding related to RSUs. On Nov 18, 2024 the reporting person was granted 109,956 RSUs; 6,872 of those RSUs vested on May 18, 2026, and the issuer mandated selling shares to cover taxes (not a discretionary sale).
- Shares owned after the transactions: not specified in the provided filing summary.
Context
This was a sell-to-cover tied to RSU vesting (tax-withholding), which is routine and does not necessarily reflect the insider’s view of the company. Sales coded "S" for tax withholding are common after awards vest; purchases would typically be interpreted as a stronger bullish signal.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-05-20$30.41/sh−249$7,572→ 244,973 total - Sale
Common Stock
[F1][F3]2026-05-20$32.15/sh−1,168$37,551→ 243,805 total - Sale
Common Stock
[F1][F4]2026-05-20$32.95/sh−1,698$55,949→ 242,107 total
Footnotes (4)
- [F1]On November 18, 2024, the holder was granted 109,956 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on November 20, 2024, of which 6,872 of these RSUs vested on May 18, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.32 - $31.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.55 - $32.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.55 - $33.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.